Diabetic retinopathy and the NMDA receptor
- Sylvia B. Smith(corresponding author)
Scholary Output:
Contribution to journal
Review article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 226-232 (7 pages)Journal (Volume, Issue Number)
Drug News and Perspectives (Volume 15, Issue 4)Publication milestones
- Published - 2002
Publication status
Published - 2002
ISSN
0214-0934Publication IDs
- Scopus: 0036087824
Publication metrics
Metrics
SciVal
FWCI
0.30
SciVal
Author count
1
SciVal
citations
20
SciVal
Paper percentile
70
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
46
Citation count
37
